The marijuana screening inventory (MSI-X): Reliability, Factor structure, and scoring criteria with a clinical sample

American Journal of Drug and Alcohol Abuse

Volumn 30, Issue 2, 2004, Pages 321-351

  Alexander, Dale E ^a   Leung, Patrick ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

Cannabis abuse; Drug abuse; Marijuana; Marijuana screening inventory (MSI X); Screening

Indexed keywords

CANNABIS;

ACCURACY; ARTICLE; CANNABIS ADDICTION; DEMOGRAPHY; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PSYCHOMETRY; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SCREENING; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MIDDLE AGED; PSYCHOMETRICS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 2942648043     PISSN: 00952990     EISSN: None     Source Type: Journal    
DOI: 10.1081/ADA-120037381     Document Type: Article

References (78)

1. Alexander D. A review of marijuana assessment dilemmas: time for marijuana specific screening methods. J. Social Work Practice in Addict 2003; 3(4):5-28.
2. Haack M, Adger H. Executive summary: strategic plan for interdisciplinary faculty development: arming the nation's health professional workforce for a new approach to substance use disorders. Substance Abuse 2002; 23(3:supplement b):1-21.
3. Teesson M, Lynskey M, Manor B, Baillie A. The structure of cannabis dependence in the community. Drug Alcohol Depend 2002; 68:255-262.
4. Alexander D. A marijuana screening inventory (experimental version): description and preliminary psychometric properties. Amer J Drug Alcohol Abuse 2003; 29(3):619-645.
5. Alexander D. Clinical pilot experiences using the marijuana screening inventory (MSI-X): screening guidelines and case illustrations. J. Social Work Practice in Addict 2003; 3(4):29-51.
6. Substance Abuse and Mental Health Services Administration. Results from the 2001 National Household Survey on Drug Abuse: Volume I. Summary of National Findings. Rockville, MD 2002. Office of Applied Studies, NHSDA Series H-17, DHHS Publication No. SMA 02-3758.
7. Johnston L, O'Malley P, Bachman J. Monitoring the Future National Survey Results on Drug Use, 1975-2000: College Students and Adults Ages 19 to 40. Bethesda, MD: National Institute on Drug Abuse, 2001. NIH publication No. 01-4925.
8. Marijuana and Medicine: Assessing the Science Base. Joy J, Watson S, Benson J, eds. Washington: Institute of Medicine, National Academy Press, 1999.
9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth edition. Text Revision, (DSM IV-TR). Washington, DC: American Psychiatric Association, 2000.
10. Substance Abuse and Mental Health Services Administration. The DASIS Report. Marijuana Admissions Increase: 1993-1999. SAMHSA Drug and Alcohol Services Information System. Office of Applied Studies, 2002. www.drugabusestatistics.samhsa.gov (accessed Feb 2003).
11. Substance Abuse and Mental Health Services Administration. Results from the 2001 National Household Survey on Drug Abuse: Volume II. Technical Appendices and Selected Data Tables. NHSDA Series H-17. Rockville, MD: Office of Applied Studies, 2002. DHHS, Publication No. SMA 02-3759.
12. Earlywine M. Understanding Marijuana: A New Look at the Scientific Evidence. New York: Oxford University Press, 2002.
13. Gerdes L. Marijuana. San Diego: Greenhaven Press, Inc, 2002.
14. National Institute of Drug Abuse. Research Report Series: Marijuana Abuse. Rockville, MD: National Institute of Health, 2002. NIH Publication No. 02-3859.
15. Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt T. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 2002; 325:1212-1213.
16. Bovaso G. Cannabis abuse as a risk factor for depressive symptoms. Am J Psychiatry 2001; 158:2033-2037.
17. Boyer C, Shafer M, Teitle E, Wibbelsman C, Seeberg D, Schachter J. Sexually transmitted diseases in a health maintenance organization teen clinic: association of race, partner's age and marijuana use. Arch Pediatr Adolesc Med 1999; 153(8):838-844.
18. Brook D, Brook J, Zhang C, Cohen P, Whiteman M. Drug use and the risk of major depressive disorder, alcohol dependence, and substance use disorders. Arch Gen Psychiatry 2002; 59:943-955.
19. Budney A, Novy P, Hughes J. Marijuana withdrawal among adults seeking treatment for marijuana dependence. Addiction 1999; 94:1311-1322.
20. Fergusson D, Horwood J, Swain-Campbell N. Cannabis use and psychological adjustment in adolescence and young adulthood. Addiction 2002; 97:1123-1135.
21. Fried P. The consequences of marijuana use during pregnancy: a review of the human literature. J Cannabis Therapeutics 2002; 2:85-104.
22. Galif E, Newcomb M, Carmona J. Prospective relationship between drug problems and work adjustment in a community sample. J Appl Psychol 2001; 86(2):337-350.
23. Gfroerer JC, Wu L-T., Penne MA. Initiation of Marijuana Use: Trends, Patterns, and Implications. Analytic Series: A-17. Rockville, MD: Substance Abuse and Mental Health Services Administration. Office of Applied Studies, 2002. DHHS Publication No. SMA 02-3711.
24. Gorman D, Derzon J. Behavioral traits and marijuana use and abuse: a meta-analysis of longitudinal studies. Addict Behav 2002; 27:193-206.
25. Grady M. Cognitive deficits associated with heavy marijuana use appear to be reversible. Nida Notes 2002; 17. Available at www.drugabuse.gov/NIDA_notes/ NNindex.
26. Green B, Ritter C. Marijuana use and depression. J Health Social Behav 2000; 41:40-49.
27. Kouri E, Pope H, Lukas S. Changes in aggressive behavior during withdrawal from long-term marijuana use. Psychopharmacology 1999; 143:302-308.
28. Lynskey M, Hall W. The effects of adolescent cannabis use on educational attainment: a review. Addiction 2000; 95:1621-1630.
29. Patton G, Coffey C, Carlin J, Degenhardt L, Lynskey M, Hall W. Cannabis use and mental health in young people: cohort study. BMJ 2002; 325:1195-1198.
30. Taylor DR, Fergusson D, Milne B, Horwood LJ, Moffitt T, Sears M, Poulton R. A longitudinal study of the effects of tobacco and cannabis exposure on lung function in young adults. Addiction 2002; 97:1055-1061.
31. Schwenk C. Marijuana and job performance: comparing the major streams of research. J Drug Issues 1998; 28:941-970.
32. Solowij N, Stephens R, Roffman R, Barbor T, Kadden R, Miller M, Christiansen K, McRee B, Vendetti J. Cognitive functioning of long term heavy cannabis users seeking treatment. JAMA 2002; 287:1123-1131.
33. Staton M, Leukefeld C, Logan T, Zimmerman R, Lynam D, Milich R. Risky sex behavior and substance use among young adults. Health Soc Work 1999; 24:147-154.
34. Ramaekers J, Robbe H, O'Hanlon J. Marijuana, alcohol and actual driving performance. Hum Psychopharmacol Clin Exp 2000; 15:551-558.
35. Zammit S, Allebeck P, Andreasson S, Lundberg I, Lewis G. Self-reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ 2002; 25:1199-2011.
36. Zickler P. Study demonstrates that marijuana smokers experience significant withdrawal. Nida Notes 2002; 17, Available at: http://www.nida.gov/ NIDA-Notes/NNVol17.
37. SAMHSA. Report to Congress on Prevention and Treatment of Co-Occurring Disorders 2002. Rockville, MD: US Dept of HHS, November 2002.
38. Presidents New Freedom Commission on Mental Health Report. July 22, 2003. Available at: http://www.mentalhealthcommission.gov (accessed July 24, 2003).
39. Dennis M, Babor T, Roebuck M, Donaldson J. Changing the focus: the case for recognizing and treating cannabis use disorders. Addiction 2002; 97(s.1):4-15.
40. Agosti V, Nunes E, Levin F. Rates of psychiatric comorbidity among US residents with lifetime cannabis dependence. Am J Drug Alcohol Abuse 2002; 28(4):643-652.
41. Fleming M. Chapter 2: screening, assessment, and intervention for substance use disorders in general health care settings. In: Haack M, Hoover A, eds. Vol. 23. Strategic Plan for Interdisciplinary Faculty Development: Arming the Nation's Health Professional Workforce for a New Approach to Substance Use Disorders. Vol. 23. Substance Abuse, 2002; (3: supplement a):319-340.
42. Swift W, Copland J, Hall W. Choosing a diagnostic cut-off for cannabis dependence. Addiction 1998; 93:1681-1692.
43. National Institute on Alcohol Abuse and Alcoholism. The Physicians Guide to Helping Patients with Alcohol Problems. Rockville, MD, 1995. NIH publication No. 95-3756.
44. Plant M. Editorial: patterns and consequences matter. Addict Res 1999; 7:463-468.
45. Ridenour T, Cottler L, Compton W, Spitznagel R, Williams R. Is there a progression from abuse disorders to dependence disorders? Addiction 2003; 98:635-644.
46. Richter L, Johnson P. Current methods of assessing substance use: a review of strengths, problems, and developments. J Drug Issues 2001; 31:809-832.
47. Riley J, Lu N, Taylor B. Drug screening: a comparison of urinalysis results from two independent laboratories. J Drug Issues 2000; 30:171-186.
48. James W, Moore D. Examining the relationship between gender and drug-using behaviors in adolescents: the use of diagnostic assessments and biochemical analyses of urine samples. J Drug Educ 1999; 29:235-249.
49. Mura P, Klintz P, Papet Y, Ruesch G, Piriou A. Evaluation of six rapid tests for screening of cannabis in sweat, saliva, and tears. Acta Clin Belg 1999; 1:35-38.
50. Cone E, Johnson R. Contact highs and urinary cannabinoid excretion after passive exposure to marijuana smoke. Clin Pharmacol Ther 1986; 40:247-256.
51. Fendrich M, Kim J. The experience and acceptability of drug testing: poll trends. J Drug Issues 2002; 32:81-96.
52. Buchan B, Dennis M, Tims F, Diamond G. Cannabis use: consistency and validity of self report, on-site urine testing and laboratory testing. Addiction 2002; 97(s1):98-108.
53. Bastiaens L, Riccardi K, Sakhrani D. The RAFFT as a screening tool for adult substance use disorders. Amer J Drug Alcohol Abuse 2002; 28(4):681-691.
54. Brown R, Rounds L. Conjoint screening questionnaires for alcohol and drug abuse. Wis Med J 1995; 94:135-140.
55. Brown R, Leonard T, Saunders L, Papasouliotis O. Two item screening test for alcohol and other drug problems. J Fam Prac 1997; 44:151-160.
56. Maisto S, Carey M, Carey K, Gordon C, Gleason J. Use of the AUDIT and DAST10 to identify alcohol and drug use disorders among adults with severe and persistent mental illness. Psych Assess 2000; 12:186-192.
57. Knight J, Shrier L, Bravender T, Farrel M, Vander-Bilt J, Shaffer H. A new brief screen for adolescent substance abuse. Arch Pediatr Med 1999; 153:591-596.
58. Group, WHO ASSIST working. The alcohol, smoking and substance involvement screening test (ASSIST): development, reliability and feasibility. Addiction 2002; 97:1183-1194.
59. Winters K. A new multiscale measure of adult substance abuse. J Subst Abuse Treat 1999; 16:237-246.
60. Santisteban D, Tejeda M, Dominicis C, Szapocznik J. An efficient tool for screening for maladaptive family functioning in adolescent drug abusers: the problem oriented screening instrument for teenagers. Amer J Drug Alcohol Abuse 1999; 25:197-206.
61. Skinner H. The drug abuse screening test (DAST). Addict Behav 1982; 7:363-371.
62. Miller G, Lazowski L. The SASSI Manual, Substance Abuse Measures, Substance Abuse Subtle Screening Inventory (SASSI-3) Manual. 2nd ed. Springville, IN: SASSI Institute, 1999.
63. McLellan A, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M. Fifth edition of the addiction severity index. J Subst Abuse Treat 1992; 9:199-213.
64. Kazmierczak D, Smyth N, Wodarski J. Screening and assessment instruments for alcohol and other drugs. Fam Ther 1999; 26(2):103-119.
65. Cooney N, Zweben A, Fleming M. Chapter 3: screening for alcohol problems and at-risk drinking in health care settings. In: Hester R, Miller W, eds. Handbook of Alcoholism Treatment Approaches. 2nd ed. Boston: Allyn & Bacon, 1995:45-60.
66. Aarons G, Brown S, Stice E, Coe M. Psychometric evaluation of the marijuana and stimulant effect expectancy questionnaires for adolescents. Addict Behav 2001; 26:219-236.
67. Budney A, Novy P, Hughes J. Marijuana withdrawal among adults seeking treatment for marijuana dependence. Addiction 1999; 94: 1311-1322.
68. Heishman S, Singleton E, Liguori A. Marijuana craving questionnaire: development and initial validation of a self-report instrument. Addiction 2001; 96:1023-1034.
69. Stephens R, Roffman R, Curtin L. Comparison of extended versus brief treatments for marijuana use. J Clin Psychol 2000; 68:898-908.
70. Edreich L, Lee E. Use of relative operating characteristic analysis in epidemiology: a method for dealing with subjective judgment. Am J Epidemiol 1981; 114:649-662.
71. Kim J, Mueller C. Introduction to Factor Analysis: What it is and How to do it. Beverly Hills, CA: Sage Publications, 1981.
72. Kim J, Mueller C. Factor Analysis: Statistical Methods and Practical Issues. Beverly Hills, CA: Sage Publications, 1981.
73. Svanum S, McGrew J. Prospective screening of substance dependence: the advantages of directness. Addict Behav 1995; 20:205-213.
74. Gfroerer J, Penne M, Pemberton M, Folsom R. Substance abuse treatment need among older adults in 2020: impact of the aging babyboom cohort. Drug Alcohol Depend 2003; 69:127-135.
75. Richter L, Johnson P. Current methods of assessing substance use: a review of strengths, problems, and developments. J Drug Issues 2001; 31:809-832.
76. Compton W, Cottler L, Dorsey K, Spitznagel E, Mager D. Comparing assessments of DSM-IV substance dependence disorders using the CIDI-SAM and SCAN. Drug Alcohol Depend 1996; 41:179-187.
77. Dziegielewski S, Johnson A, Webb E. DSM-IV and social work professionals: a continuing education evaluation. Social Work in Mental Health 2002; 1:27-41.
78. Meyer G. Chapter 3: implications of information-gathering methods for a refined taxonomy of psychopathology. In: Beutler L, Malik M, eds. Rethinking the DSM: A Psychological Perspective. Washington: American Psychological Press, 2002:69-106.